About Dora Mitchell
Form D filings for Interius BioTherapeutics from 2021 to 2024 list Dora Mitchell as executive officer.
Dora Mitchell first appears on SEC filings in 2021.
Experience
This experience comes from SEC filings. The years are when the filings name Dora Mitchell in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Dora Mitchell works with at each company, as listed on that company's latest Form D.
Interius BioTherapeutics, Inc. · Form D, Jun 3, 2024
LM
Leon Moulder
Director
TK
Tomas Kiselak
Director
BC
Bihua Chen
Director
LJ
Leon Moulder, Jr.
Director
PD
Philip Johnson, M.D.
President and Chief Executive Officer, director